Journals / Türk Nefroloji Diyaliz ve Transplantasyon Dergisi / 2012 / Cilt: 21 - Sayı: 3

Bartter syndrome type І: A case report

Bartter sendromu tip І: Bir olgu sunumu

Pages
307–309
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, a patient with Bartter syndrome type І is presented and the clinical and laboratory fi ndings and treatment are reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Salt-losing tubulopathies with secondary hyperaldosteronism are genetic disorders that involve the thick ascending limb of Henle's loop and the distal convoluted tubule.
📊
Key Findings & Data:Bartter syndrome type І is a saltlosing renal tubular disorder and mimics the laboratory features of chronic treatment with loop diuretics such as hyponatremia, hypokalemia, hypercalciuria.
💡
Conclusion & Impact:In this report, a patient with Bartter syndrome type І is presented and the clinical and laboratory fi ndings and treatment are reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Salt-losing tubulopathies with secondary hyperaldosteronism are genetic disorders that involve the thick ascending limb of Henle's loop and the distal convoluted tubule. Bartter syndrome type І is a saltlosing renal tubular disorder and mimics the laboratory features of chronic treatment with loop diuretics such as hyponatremia, hypokalemia, hypercalciuria. In this report, a patient with Bartter syndrome type І is presented and the clinical and laboratory fi ndings and treatment are reviewed.

Özet

Sekonder hiperaldosteronizmin eşlik ettiği tuz kaybettiren nefropatiler, Henle kulpunun çıkan kalın kolu ve distal kıvrımlı tubulü ilgilendiren kalıtımsal bozukluklara bağlı gelişen bir grup sendromdur. Bartter sendromu tip І, bu grupta yer alır ve hiponatremi, hipopotasemi, hiperkalsiüri gibi ‘loop' diüretikleri ile tedaviyi taklit eden laboratuvar özelliklere sahiptir.Bu yazıda, Bartter sendromu tip І tanısı alan bir hasta sunulmakta, sendromun klinik - laboratuvar bulguları ve tedavisi gözden geçirilmektedir.

🔖

Cite This Article

USLU, A. G., ÇOMAK, E., OYGÜR, N., ÖZTEKİN, O., KALAY, S., DOĞAN, Ç. S., AKMAN, S., KOYUN, M. (2022). Bartter syndrome type І: A case report. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 21 - Sayı: 3, 307–309. https://ajindex.com/articles/636402

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Devuyst O: Tubular Disorders of Electrolye Regulation. In: Avner ED, Harmon WE, Nıaudet P, Yoshikawa N, Pediatric Nephrology, (6th ed). Berlin Heidelberg: Springer-Verlag, 2009; 929-935 2. Seyberth HW, Schlingmann KP: Bartter- and Gitelman-like syndromes: Salt-losing tubulopathies with loop or DCT defects. Pediatr Nephrol 2011; 26: 1789-1802 3. Reinalter SC, Jeck N, Brochhausen C, Watzer B, Nüsing RM, Seyberth HW, Kömhoff M: Role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome. Kidney Int 2002; 62: 253-260 4. Haycock GB: The infl uence of sodium on growth in infancy. Pediatr Nephrol 1993; 7: 871-875 5. Gil-Peña H, Mejia N, Alvarez-Garcia O, Loredo V, Santos F: Longitudinal growth in chronic hypokalemic disorders. Pediatr Nephrol 2010; 25: 733-737 6. Seidel C, Reinalter S, Seyberth HW, Schärer K: Pre-pubertal growth in the hyperprostaglandin E syndrome. Pediatr Nephrol 1995; 9: 723-728 7. Vaisbich MH, Fujimura MD, Koch VH: Bartter syndrome: Benefi ts and side effects of long-term treatment. Pediatr Nephrol 2004; 19: 858-863 8. Puricelli E, Bettinelli A, Borsa N, Sironi F, Mattiello C, Tammaro F, Tedeschi S, Bianchetti MG; Italian Collaborative Group for Bartter Syndrome: Long-term follow-up of patients with Bartter syndrome type I and II. Nephrol Dial Transplant 2010; 25: 2976-2981 9. Kleta R, Bockenhauer D: Bartter syndromes and other salt-losing tubulopathies. Nephron Physiol 2006; 104: 73-80